The consolidation of suits alleging Gencor Nutrients Inc., General Nutrition Center and others falsely market Testofen—an extract of the herb fenugreek—as a testosterone booster is set for a March 26 hearing before the U.S. Judicial Panel on Multidistrict Litigation (In re Testofen Mktg. and Sales Prac. Litig., J.P.M.L., 2612, hearing set 3/26/15).
Gencor sells Testofen to makers of nutritional supplements for inclusion in their products, according to a recent motion for consolidation by plaintiffs Michael Ryan and others.
At least 22 Testofen-containing products, made by 10 companies, are labeled, marketed and sold as clinically proven testosterone boosters. ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.